Inventor
AL-AWAR RIMA
CA7 patents
⚠️ This page may combine multiple inventors who share the name “AL-AWAR RIMA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ONTARIO INSTITUTE FOR CANCER RES OICR
4 patentsUS11518764B2Dec 6, 2022
Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein interaction
ONTARIO INSTITUTE FOR CANCER RES OICR3 citations67
US11576981B2Feb 14, 2023
Acyl hydrazone linkers, methods and uses thereof
ONTARIO INSTITUTE FOR CANCER RES OICR1 citations59
US11850287B2Dec 26, 2023
Heterocyclic acyl hydrazone linkers, methods and uses thereof
ONTARIO INSTITUTE FOR CANCER RES OICR0 citations48
US11242351B2Feb 8, 2022
Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereof
ONTARIO INSTITUTE FOR CANCER RES OICR0 citations47
PROPELLON THERAPEUTICS INC
3 patentsUS11174250B2Nov 16, 2021
Substituted carboxamides as inhibitors of WDR5 protein-protein binding
PROPELLON THERAPEUTICS INC3 citations67
US12264147B2Apr 1, 2025
Substituted carboxamides as inhibitors of WDR5 protein-protein binding
PROPELLON THERAPEUTICS INC0 citations55
US11319299B2May 3, 2022
Substituted carboxamides as inhibitors of WDR5 protein-protein binding
PROPELLON THERAPEUTICS INC1 citations55